50至65岁患者外科主动脉瓣置换类型选择与中期结局:AUTHEARTVISIT研究
该注册队列研究基于奥地利全国医保数据(2010-2020),比较50至65岁患者行孤立外科主动脉瓣置换时机械瓣与生物瓣的结局。共纳入机械瓣组1018例、生物瓣组2743例,经倾向评分匹配后,机械瓣组全因死亡风险显著更低(HR 1.352,P=0.003),主要不良心脏事件(HR 1.182,P=0.03)和再手术风险(HR 2.338,P=0.002)也更高。两组卒中与出血风险相似。结论提示该年龄段应重新评估生物瓣日益增多的使用趋势。
要点
- 50至65岁外科主动脉瓣置换患者中,机械瓣组全因死亡风险显著低于生物瓣组。
- 生物瓣组主要不良心脏事件和再手术风险显著高于机械瓣组。
- 两组卒中与出血风险相似,倾向评分匹配后结论仍显著。
核心结论
- 在50至65岁行外科主动脉瓣置换的患者中,机械瓣与更好的长期生存、更少主要不良事件和更低再手术需求相关。
- 研究结果提示需要重新评估该年龄段中生物瓣使用增加的趋势。
研究设计与样本
- 纳入行孤立外科主动脉瓣置换的患者,按瓣膜类型分为机械瓣组(1018例)和生物瓣组(2743例)。
- 采用Cox或竞争风险回归模型评估结局,并使用倾向评分匹配减少基线差异。
主要发现
- 机械瓣组全因死亡风险显著低于生物瓣组(HR 1.352;P=0.003)。
- 生物瓣组主要不良心脏事件风险更高(HR 1.182;P=0.03)。
- 生物瓣组再手术风险更高(HR 2.338;P=0.002)。
- 两组卒中与出血风险相似。
- 所有发现在倾向评分匹配后仍显著。
临床怎么用
- 对于50至65岁拟行外科主动脉瓣置换的患者,选择机械瓣可能带来更优的长期生存和更低的再手术风险。
- 在瓣膜类型决策时,应结合患者个体情况重新评估生物瓣的适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In recent years, the use of biological prosthetic valves has increased in patients under 65 years of age. This study evaluated overall survival, major adverse cardiac events and reoperation risk following surgical aortic valve replacement using either mechanical or biological prostheses in patients aged 50 to 65 years, aiming to provide data to support optimal valve selection in this group. METHODS: A registry-based cohort study was conducted using nationwide Austrian health insurance data from 1 January 2010 to 31 December 2020. Patients undergoing isolated surgical aortic valve replacement were classified based on valve type into mechanical or biological groups. The primary outcome was all-cause mortality. Secondary outcomes included major adverse cardiac events, reoperation, stroke, bleeding and survival after reoperation. Outcomes were assessed using Cox or competing risk regression models. Propensity score matching was used to reduce baseline differences. RESULTS: In the study cohort, 1018 patients were categorized to the mechanical and 2743 to the biological group. Patients who received mechanical valves had a significantly lower risk of death compared to those with biological valves (hazard ratio 1.352; P = 0.003). The biological group also had higher risks of major adverse cardiac events (hazard ratio 1.182; P = 0.03) and reoperation (hazard ratio 2.338; P = 0.002). Stroke and bleeding risks were similar between groups. All findings remained significant after propensity score matching. CONCLUSIONS: Among patients aged 50 to 65 years undergoing surgical aortic valve replacement, mechanical valves were associated with improved long-term survival, fewer major adverse events, and a lower need for repeat surgery. These findings suggest a need to re-evaluate the increasing use of biological valves in this age group.
引用
- Florian A, Auer J, Reichardt B, et al. The choice of surgical aortic valve replacement type and mid-term outcomes in 50 to 65-year-olds: results of the AUTHEARTVISIT study. Eur J Cardiothorac Surg. 2025. PMID: 40574662. doi:10.1093/ejcts/ezaf200
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。